


Searching News Database: LINX
HSMN NewsFeed - 22 Sep 2014
New Study Shows Magnetic Implant is an Important Break-Through in the Treatment of Reflux Disease
New Study Shows Magnetic Implant is an Important Break-Through in the Treatment of Reflux Disease
HSMN NewsFeed - 13 Feb 2014
MYOS Corporation Announces Appointment of Robert C. Ashton, Jr., M.D., as Chief Medical Officer
MYOS Corporation Announces Appointment of Robert C. Ashton, Jr., M.D., as Chief Medical Officer
HSMN NewsFeed - 15 Apr 2013
Abbott Initiates Voluntary Recall of FreeStyle InsuLinx(R) Blood Glucose Meters in the United States
Abbott Initiates Voluntary Recall of FreeStyle InsuLinx(R) Blood Glucose Meters in the United States
HSMN NewsFeed - 19 Sep 2012
Torax Medical Secures $30M Financing to Commercialize Pioneering Treatment for Reflux Disease
Torax Medical Secures $30M Financing to Commercialize Pioneering Treatment for Reflux Disease
HSMN NewsFeed - 13 Jan 2012
Torax Medical’s LINX(R) Reflux Management System Receives Unanimous Recommendation From FDA Advisory Panel
Torax Medical’s LINX(R) Reflux Management System Receives Unanimous Recommendation From FDA Advisory Panel
HSMN NewsFeed - 14 Nov 2011
Torax Medical Receives CE Mark for the FENIX Continence Restoration System
Torax Medical Receives CE Mark for the FENIX Continence Restoration System
HSMN NewsFeed - 7 Sep 2010
Medtronic Announces First European Implant of New Drug-eluting Stent at Southampton General Hospital, UK
Medtronic Announces First European Implant of New Drug-eluting Stent at Southampton General Hospital, UK
HSMN NewsFeed - 23 Feb 2010
BSD Medical Reports Publication of Chinese Study Using the BSD-2000 Hyperthermia System to Treat Lung Cancer
BSD Medical Reports Publication of Chinese Study Using the BSD-2000 Hyperthermia System to Treat Lung Cancer
HSMN NewsFeed - 27 Jan 2010
Juvaris BioTherapeutics Completes Second Close on $25 Million Series B Financing
Juvaris BioTherapeutics Completes Second Close on $25 Million Series B Financing
HSMN NewsFeed - 17 Sep 2009
Juvaris BioTherapeutics Announces First Close on $25 million Series B Financing
Juvaris BioTherapeutics Announces First Close on $25 million Series B Financing
HSMN NewsFeed - 15 Jun 2009
Hollis-Eden Pharmaceuticals Announces Appointment of Dr. James M. Frincke President and CEO
Hollis-Eden Pharmaceuticals Announces Appointment of Dr. James M. Frincke President and CEO
HSMN NewsFeed - 14 May 2009
Medtronic Completes Enrollment in International Post-Market Study of Resolute Drug-Eluting Stent
Medtronic Completes Enrollment in International Post-Market Study of Resolute Drug-Eluting Stent
HSMN NewsFeed - 15 Jan 2009
St. Jude Medical Announces Publication of 20-year Durability in Aortic and Mitral Stented Tissue Valves
St. Jude Medical Announces Publication of 20-year Durability in Aortic and Mitral Stented Tissue Valves
HSMN NewsFeed - 8 Jan 2009
Satori Pharmaceuticals Raises $22M; Names Former Senior Pfizer Executive as CEO
Satori Pharmaceuticals Raises $22M; Names Former Senior Pfizer Executive as CEO
HSMN NewsFeed - 27 Oct 2008
St. Jude Medical Announces Publication of 20-Year Durability Data on Tissue Heart Valve
St. Jude Medical Announces Publication of 20-Year Durability Data on Tissue Heart Valve
HSMN NewsFeed - 15 Sep 2008
Medtronic Starts U.S. and International Trials of Endeavor(R) Resolute Drug-Eluting Coronary Stent
Medtronic Starts U.S. and International Trials of Endeavor(R) Resolute Drug-Eluting Coronary Stent
HSMN NewsFeed - 4 Sep 2008
Microfabrica Secures $22.5 Million Funding to Grow Its Medical Device Business
Microfabrica Secures $22.5 Million Funding to Grow Its Medical Device Business
HSMN NewsFeed - 26 Nov 2007
St. Jude Medical Announces FDA Approval of Epic Stented Tissue Valve with Anti-Calcification Technology
St. Jude Medical Announces FDA Approval of Epic Stented Tissue Valve with Anti-Calcification Technology
HSMN NewsFeed - 24 Jul 2007
St. Jude Medical Announces First Clinical Trial Implant of Trifecta Stented Tissue Heart Valve
St. Jude Medical Announces First Clinical Trial Implant of Trifecta Stented Tissue Heart Valve
HSMN NewsFeed - 17 Jan 2007
Cerus Announces French Regulatory Approval of the INTERCEPT Blood System for Plasma
Cerus Announces French Regulatory Approval of the INTERCEPT Blood System for Plasma
HSMN NewsFeed - 21 Nov 2006
Cerus Corporation Announces European Regulatory Approval for the INTERCEPT Blood System for Plasma
Cerus Corporation Announces European Regulatory Approval for the INTERCEPT Blood System for Plasma
HSMN NewsFeed - 25 Oct 2006
Medtronic Announces Positive Results for Endeavor RESOLUTE Drug-Eluting Coronary Stent System
Medtronic Announces Positive Results for Endeavor RESOLUTE Drug-Eluting Coronary Stent System
Additional items found! 29
Members Archive contains
29 additional stories matching:
LINX
(Password required)
LINX
(Password required)
